Incidence of cardiovascular events among tildrakizumab-treated patients with moderate to severe plaque psoriasis: Pooled data from 3 large randomized clinical trials

被引：0
|
作者：
Bissonnette, Robert [1 ]
Fernandez-Penas, Pablo [2 ,3 ]
Puig, Lluis [4 ]
Mendelsohn, Alan M. [5 ]
Rozzo, Stephen J. [5 ]
Menter, Alan [6 ,7 ]
机构：
[1] Innovaderm Res, Montreal, PQ, Canada
[2] Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia
[3] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[4] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Barcelona, Spain
[5] 5Sun Pharmaceut Ind Inc, Princeton, NJ USA
[6] Baylor Scott & White, Div Dermatol, Dallas, TX USA
[7] Texas A&M Coll Med, Dallas, TX USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
9796
引用
收藏
页码：AB79 / AB79
页数：1
相关论文
共 50 条
  • [21] Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials
    Blauvelt, A.
    Reich, K.
    Lebwohl, M.
    Burge, D.
    Arendt, C.
    Peterson, L.
    Drew, J.
    Rolleri, R.
    Gottlieb, A. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (03) : 546 - 552
  • [22] Bimekizumab in patients with moderate-to-severe plaque psoriasis by bodyweight: pooled results from phase III trials
    Pinter, A.
    Strober, B.
    Rosmarin, D.
    Gisondi, P.
    Vanvoorden, V.
    Peterson, L.
    Madden, C.
    de Cuyper, D.
    Warren, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E48 - E49
  • [23] Bimekizumab efficacy and safety through 2 years in patients with moderate to severe plaque psoriasis: Analysis of pooled data from five phase 3/3b clinical trials
    Penas, Pablo Fernandez
    Gordon, Kenneth B.
    Armstrong, April W.
    Lebwohl, Mark
    Blauvelt, Andrew
    Paul, Carle
    Wang, Maggie
    Vanvoorden, Veerle
    Madden, Cynthia
    Gomez, Natalie Nunez
    Deherder, Delphine
    Thaci, Diamant
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 20 - 20
  • [24] Impact of Adalimumab on Symptoms of Psoriatic Arthritis in Patients with Moderate to Severe Psoriasis: A Pooled Analysis of Randomized Clinical Trials
    Mease, Philip J.
    Signorovitch, James
    Yu, Andrew P.
    Wu, Eric Q.
    Gupta, Shiraz R.
    Bao, Yanjun
    Mulani, Parvez M.
    DERMATOLOGY, 2010, 220 (01) : 1 - 7
  • [25] Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials
    McMichael, Amy
    Desai, Seemal R.
    Qureshi, Aamir
    Rastogi, Shipra
    Alexis, Andrew F.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (02) : 267 - 276
  • [26] Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials
    Amy McMichael
    Seemal R. Desai
    Aamir Qureshi
    Shipra Rastogi
    Andrew F. Alexis
    American Journal of Clinical Dermatology, 2019, 20 : 267 - 276
  • [27] Efficacy and safety of oral tofacitinib in North American patients with moderate to severe plaque psoriasis: Pooled analyses of data from randomized phase 3 studies
    Korman, Neil J.
    King, Brett
    Wolk, Robert
    Tan, Huaming
    Kaur, Mandeep
    Robertson, Debbie
    Langley, Richard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB247 - AB247
  • [28] Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
    Michael Sticherling
    Arjen F. Nikkels
    Ashraf M. Hamza
    Pearl Kwong
    Jacek C. Szepietowski
    Mahira El Sayed
    Pierre-Dominique Ghislain
    Alkes A. Khotko
    Manmath Patekar
    Christine-Elke Ortmann
    Pascal Forrer
    Philemon Papanastasiou
    Deborah Keefe
    American Journal of Clinical Dermatology, 2023, 24 : 821 - 835
  • [29] Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
    Sticherling, Michael
    Nikkels, Arjen F.
    Hamza, Ashraf M.
    Kwong, Pearl
    Szepietowski, Jacek C.
    El Sayed, Mahira
    Ghislain, Pierre-Dominique
    Khotko, Alkes A.
    Patekar, Manmath
    Ortmann, Christine-Elke
    Forrer, Pascal
    Papanastasiou, Philemon
    Keefe, Deborah
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 821 - 835
  • [30] Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)
    Blauvelt, Andrew
    Papp, Kim A.
    Lebwohl, Mark G.
    Green, Lawrence J.
    Hsu, Sylvia
    Bhatt, Varsha
    Rastogi, Shipra
    Pillai, Radhakrishnan
    Israel, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (02) : 372 - 374
12345